Sosnowska, B.; Adach, W.; Surma, S.; Rosenson, R.S.; Banach, M.
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. J. Clin. Med. 2023, 12, 168.
https://doi.org/10.3390/jcm12010168
AMA Style
Sosnowska B, Adach W, Surma S, Rosenson RS, Banach M.
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. Journal of Clinical Medicine. 2023; 12(1):168.
https://doi.org/10.3390/jcm12010168
Chicago/Turabian Style
Sosnowska, Bożena, Weronika Adach, Stanisław Surma, Robert S. Rosenson, and Maciej Banach.
2023. "Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia" Journal of Clinical Medicine 12, no. 1: 168.
https://doi.org/10.3390/jcm12010168
APA Style
Sosnowska, B., Adach, W., Surma, S., Rosenson, R. S., & Banach, M.
(2023). Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. Journal of Clinical Medicine, 12(1), 168.
https://doi.org/10.3390/jcm12010168